Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Carlyle (CG)

Carlyle Group Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CG
DateTimeSourceHeadlineSymbolCompany
17/06/202411:49IH Market NewsGoldman Sachs Raises S&P 500 Forecast for 2024; Disney Secures Deadpool & Wolverine in Chinese Cinemas, and MoreNASDAQ:CGCarlyle Group Inc
13/06/202415:15GlobeNewswire Inc.Oregon Health Authority Selects Acentra Health to Implement Division of the State’s Health-Related Social Needs Benefits for 1115 Medicaid Waiver DemonstrationNASDAQ:CGCarlyle Group Inc
11/06/202416:02GlobeNewswire Inc.Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National CapitalNASDAQ:CGCarlyle Group Inc
17/05/202412:36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNASDAQ:CGCarlyle Group Inc
07/05/202423:14GlobeNewswire Inc.Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended 2024, Declares Second Quarter 2024 Dividends of $0.47 Per Common ShareNASDAQ:CGCarlyle Group Inc
02/05/202417:54GlobeNewswire Inc.Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access CommissionNASDAQ:CGCarlyle Group Inc
30/04/202421:05PR Newswire (US)Carlyle Credit Income Fund Schedules Second Quarter 2024 Financial Results and Investor Conference CallNASDAQ:CGCarlyle Group Inc
11/04/202421:05GlobeNewswire Inc.Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial ResultsNASDAQ:CGCarlyle Group Inc
05/04/202412:38IH Market NewsApple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More UpdatesNASDAQ:CGCarlyle Group Inc
01/04/202413:30Business WireClinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding AgreementNASDAQ:CGCarlyle Group Inc
26/03/202413:22GlobeNewswire Inc.Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and SolutionsNASDAQ:CGCarlyle Group Inc
26/03/202411:20IH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNASDAQ:CGCarlyle Group Inc
21/03/202416:10Business WireSER Welcomes New Investment from TA to Accelerate GrowthNASDAQ:CGCarlyle Group Inc
21/03/202416:10Business WireSER begrüßt neues Investment von TA zur WachstumsbeschleunigungNASDAQ:CGCarlyle Group Inc
05/03/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
05/03/202421:10Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CGCarlyle Group Inc
04/03/202411:05GlobeNewswire Inc.Carlyle Secured Lending, Inc. Names Justin Plouffe CEO and Member of the Board of DirectorsNASDAQ:CGCarlyle Group Inc
29/02/202411:11IH Market NewsShares of WW International Plummet after Oprah Exits, EA Announces Workforce Reduction and Restructuring Plan, and Latest NewsNASDAQ:CGCarlyle Group Inc
26/02/202422:49GlobeNewswire Inc.Carlyle Secured Lending, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results, Increases Base Dividend to $0.40 Per Common Share and Declares First Quarter 2024 Dividends of $0.48 Per Common ShareNASDAQ:CGCarlyle Group Inc
16/02/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
15/02/202421:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CGCarlyle Group Inc
12/02/202423:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CGCarlyle Group Inc
12/02/202422:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CGCarlyle Group Inc
12/02/202421:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CGCarlyle Group Inc
12/02/202421:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CGCarlyle Group Inc
09/02/202402:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
09/02/202402:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
09/02/202402:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
09/02/202402:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGCarlyle Group Inc
07/02/202421:31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CGCarlyle Group Inc
 Showing the most relevant articles for your search:NASDAQ:CG